Corteva, Inc. CTVA
78.52
(0.93)
(1.17%)
as of 25 Sep
- Market cap
- $53.0B
- P/E
- 52.0×
Follow CTVA
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Corteva, Inc. (CTVA) Revenue
Corteva, Inc.'s revenue for fiscal 2025 was $17.4B, unchanged from fiscal 2024. Over the twelve months to 30 June 2026 it was $17.8B. Over the past ten years it has ranged from $10.7B (fiscal 2017) to $23.2B (fiscal 2016); the current reading is higher than 80% of that period. Corteva, Inc. ranks 2nd of 18 Agricultural Inputs companies by revenue.
Revenue, annual
Annual
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $17.4B | 2.92% |
| FY2024 | $16.9B | (1.85%) |
| FY2023 | $17.2B | (1.31%) |
| FY2022 | $17.5B | 11.50% |
| FY2021 | $15.7B | 10.11% |
| FY2020 | $14.2B | 2.68% |
| FY2019 | $13.8B | (3.09%) |
| FY2018 | $14.3B | 33.72% |
| FY2017 | $10.7B | (53.99%) |
| FY2016 | $23.2B | — |
Quarterly
| Period | Revenue | Change |
|---|---|---|
| Jun 2026 | $6.4B | 30.05% |
| Mar 2026 | $4.9B | 25.45% |
| Dec 2025 | $3.9B | 49.35% |
| Sep 2025 | $2.6B | (59.45%) |
| 28 more quarters | Free account |
Against its own ten years
Low $10.7B
High $23.2B
Ten-year median
$16.3B
Current reading's percentile
80
Revenue against peers
| Company | Revenue |
|---|---|
| NTR Nutrien Ltd. compare | $28.2B |
| CTVA Corteva, Inc. | $17.8B |
| MOS The Mosaic Company compare | $12.2B |
| CF CF Industries Holdings, Inc. compare | $7.7B |
| ICL ICL Group Ltd. compare | $7.7B |
| SMG The Scotts Miracle-Gro Company compare | $3.5B |
| FMC FMC Corporation compare | $3.3B |
| UAN CVR Partners, LP compare | $676.9M |
| IPI Intrepid Potash, Inc compare | $301.6M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CTVA
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement